News
10h
Nuravax Inc., a biotechnology company pioneering immunotherapy for neurodegenerative disorders, has been awarded a $3 million ...
Deerfield Management Company, L.P., today announced the closing of the Deerfield Healthcare Innovations Fund III, a fund of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback